Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features
出版年份 2015 全文链接
标题
Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features
作者
关键词
-
出版物
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 182, Issue 2, Pages 119-131
出版商
Wiley
发表日期
2015-07-07
DOI
10.1111/cei.12677
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Polymorphisms and functional haplotype in PADI4: Further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population
- (2015) Iris Paola Guzmán-Guzmán et al. IMMUNOLOGY LETTERS
- Non-HLA genes PTPN22, CDK6 and PADI4 are associated with specific autoantibodies in HLA-defined subgroups of rheumatoid arthritis
- (2014) Omri Snir et al. ARTHRITIS RESEARCH & THERAPY
- Emerging cell and cytokine targets in rheumatoid arthritis
- (2013) Gerd R. Burmester et al. Nature Reviews Rheumatology
- Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity
- (2013) E. Darrah et al. Science Translational Medicine
- NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis
- (2013) R. Khandpur et al. Science Translational Medicine
- Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile
- (2012) Karin Lundberg et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibodies to PAD4 and BRAF in rheumatoid arthritis
- (2012) Isabelle Auger et al. AUTOIMMUNITY REVIEWS
- Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: An Italian multicentric study and review of the literature
- (2012) Elena Bartoloni et al. AUTOIMMUNITY REVIEWS
- The protein arginine deiminases: Structure, function, inhibition, and disease
- (2012) Kevin L. Bicker et al. BIOPOLYMERS
- Admixture and population structure in Mexican-Mestizos based on paternal lineages
- (2012) Gabriela Martínez-Cortés et al. JOURNAL OF HUMAN GENETICS
- High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
- (2012) Steve Eyre et al. NATURE GENETICS
- Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis
- (2012) William P. Arend et al. Nature Reviews Rheumatology
- Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis
- (2012) Jeremy Sokolove et al. PLoS One
- Autodeimination of Protein Arginine Deiminase 4 Alters Protein–Protein Interactions but Not Activity
- (2011) Jessica L. Slack et al. BIOCHEMISTRY
- Citrullination of autoantigens: Upstream of TNFα in the pathogenesis of rheumatoid arthritis
- (2011) Anne-Marie Quirke et al. FEBS LETTERS
- Anti-CCP antibodies: the past, the present and the future
- (2011) Walther J. van Venrooij et al. Nature Reviews Rheumatology
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis
- (2010) Jason R. Kolfenbach et al. ARTHRITIS AND RHEUMATISM
- Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor
- (2010) Jeremy Sokolove et al. ARTHRITIS AND RHEUMATISM
- Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation
- (2010) Felipe Andrade et al. ARTHRITIS AND RHEUMATISM
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
- (2010) Pingxin Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis
- (2009) K. Raza et al. ANNALS OF THE RHEUMATIC DISEASES
- Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review
- (2009) J J Luime et al. ANNALS OF THE RHEUMATIC DISEASES
- Rheumatoid arthritisâspecific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen
- (2009) Isabelle Auger et al. ARTHRITIS AND RHEUMATISM
- Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis
- (2009) Ernst Wagner et al. RHEUMATOLOGY INTERNATIONAL
- Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis
- (2008) Michelle L. Harris et al. ARTHRITIS AND RHEUMATISM
- Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis
- (2008) Andrew Kinloch et al. ARTHRITIS AND RHEUMATISM
- Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis–specific autoantibodies to citrullinated proteins complexed with fibrinogen
- (2008) Cyril Clavel et al. ARTHRITIS AND RHEUMATISM
- Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
- (2008) Jennie Ursum et al. ARTHRITIS RESEARCH & THERAPY
- Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
- (2008) Pascale Roland et al. ARTHRITIS RESEARCH & THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now